XTNT Stock Summary and Trading Ideas (Xtant Medical Hldgs | AMEX:XTNT)

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Hldgs trades on the AMEX stock market under the symbol XTNT.

As of January 17, 2025, XTNT stock price was flat at $0.52 with 27,726 million shares trading.

XTNT has a market cap of $72.28 million. This is considered a Micro Cap stock.

Last quarter Xtant Medical Hldgs reported $28 million in Revenue and -$.04 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.02.

In the last 3 years, XTNT traded as high as $1.45 and as low as $.33.

The top ETF exchange traded funds that XTNT belongs to (by Net Assets): VTI, VXF.

XTNT has underperformed the market in the last year with a price return of -52.3% while the SPY ETF gained +28.0%. XTNT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.0% and -1.3%, respectively, while the SPY returned +3.0% and +1.0%, respectively.

XTNT support price is $.47 and resistance is $.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XTNT shares will trade within this expected range on the day.